Award
SPE2D826F17U3: AMERISOURCEBERGEN DRUG CORP
4571815808!PV PHARM BRANCH, VENDOR, CAGE 0U9U0
Recipient
AMERISOURCEBERGEN DRUG CORP
Status
FY2026 transaction; performance ended in 2025 or later
PIID
SPE2D826F17U3
Awarding agency
Department of Defense
Dates
May 13, 2026 – May 14, 2026
Obligated amount
$4.3M
Outlayed amount
Not available
Current award amount
$4.3M
Potential award amount
Not available
This contract appears because USAspending reports an award transaction in FY2026 and its reported performance end date is in 2025 or later, or no end date is reported. A transaction can be a modification or administrative action; it does not by itself mean work was actively performed that year. The obligation shown is the cumulative prime-award obligation, not necessarily the amount newly obligated during FY2026. Federal data last updated October 24, 2026.
View original USAspending source ↗For researchers
Cite this page
The Paper Trail Project. “SPE2D826F17U3: AMERISOURCEBERGEN DRUG CORP.” Accessed November 7, 2026. https://www.papertrailproject.org/awards/spe2d826f17u3-361262638
Record last updated 2026-10-24. Sources: USAspending.gov. Verify consequential claims against the linked original records.